nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCA—periosteum—bone cancer	0.0626	0.464	CbGeAlD
Ingenol Mebutate—PRKCD—connective tissue—bone cancer	0.0198	0.147	CbGeAlD
Ingenol Mebutate—PRKCD—tendon—bone cancer	0.0136	0.101	CbGeAlD
Ingenol Mebutate—PRKCD—bone marrow—bone cancer	0.0132	0.0978	CbGeAlD
Ingenol Mebutate—PRKCA—connective tissue—bone cancer	0.0109	0.0809	CbGeAlD
Ingenol Mebutate—PRKCA—tendon—bone cancer	0.00751	0.0556	CbGeAlD
Ingenol Mebutate—PRKCA—spinal cord—bone cancer	0.00724	0.0537	CbGeAlD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—MDM2—bone cancer	0.00167	0.00193	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways in Glioblastoma—TP53—bone cancer	0.00167	0.00192	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—BRAF—bone cancer	0.00166	0.00192	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Platelet activation, signaling and aggregation—IL3—bone cancer	0.00164	0.0019	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—BRAF—bone cancer	0.00163	0.00189	CbGpPWpGaD
Ingenol Mebutate—PRKCD—ErbB1 downstream signaling—EGFR—bone cancer	0.00163	0.00188	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—GNA11—bone cancer	0.00162	0.00188	CbGpPWpGaD
Ingenol Mebutate—PRKCD—BDNF signaling pathway—JUN—bone cancer	0.00161	0.00186	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—GRM1—bone cancer	0.00159	0.00184	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB Signaling Pathway—EGFR—bone cancer	0.00159	0.00184	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—MDM2—bone cancer	0.00157	0.00181	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—MDM2—bone cancer	0.00157	0.00181	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—MDM2—bone cancer	0.00155	0.0018	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Thromboxane A2 receptor signaling—EGFR—bone cancer	0.00155	0.00179	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—BRCA2—bone cancer	0.00154	0.00178	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—MDM2—bone cancer	0.00154	0.00178	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—MDM2—bone cancer	0.00153	0.00177	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—RFC1—bone cancer	0.00152	0.00176	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Myometrial Relaxation and Contraction Pathways—JUN—bone cancer	0.00152	0.00175	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Insulin Signaling—JUN—bone cancer	0.00148	0.00171	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—IL3—bone cancer	0.00147	0.0017	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—JUN—bone cancer	0.00146	0.00169	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—RB1—bone cancer	0.00146	0.00169	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—GRM1—bone cancer	0.00145	0.00167	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—JUN—bone cancer	0.00142	0.00164	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—BRAF—bone cancer	0.00142	0.00164	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Wnt Signaling Pathway and Pluripotency—TP53—bone cancer	0.0014	0.00162	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—MDM2—bone cancer	0.00139	0.00161	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—KIT—bone cancer	0.00137	0.00159	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—ATF1—bone cancer	0.00137	0.00158	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—ATF1—bone cancer	0.00136	0.00157	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—KIT—bone cancer	0.00136	0.00157	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—EGFR—bone cancer	0.00136	0.00157	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB Signaling Pathway—TP53—bone cancer	0.00134	0.00154	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—NR1I2—bone cancer	0.00131	0.00152	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—KIT—bone cancer	0.00131	0.00152	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Mitotic Prophase—RB1—bone cancer	0.0013	0.00151	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—BRAF—bone cancer	0.0013	0.0015	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—BRAF—bone cancer	0.00127	0.00147	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—KIT—bone cancer	0.00123	0.00143	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signaling of activated FGFR—EGFR—bone cancer	0.00123	0.00142	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—KIT—bone cancer	0.00123	0.00142	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—KIT—bone cancer	0.00122	0.00141	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway and Pluripotency—JUN—bone cancer	0.00122	0.00141	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—KIT—bone cancer	0.00122	0.00141	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—NDUFA12—bone cancer	0.0012	0.00139	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—PTGS2—bone cancer	0.0012	0.00139	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—JUN—bone cancer	0.00119	0.00137	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signal transduction—EGFR—bone cancer	0.00116	0.00134	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—BRAF—bone cancer	0.00115	0.00133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—BRAF—bone cancer	0.00115	0.00133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—TP53—bone cancer	0.00115	0.00133	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR—EGFR—bone cancer	0.00115	0.00133	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—EGFR—bone cancer	0.00115	0.00133	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—EGFR—bone cancer	0.00114	0.00132	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—KIT—bone cancer	0.00114	0.00132	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—KIT—bone cancer	0.00114	0.00132	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—CDK4—bone cancer	0.00114	0.00132	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—EGFR—bone cancer	0.00114	0.00132	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—EGFR—bone cancer	0.00114	0.00132	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—KIT—bone cancer	0.00113	0.00131	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—KIT—bone cancer	0.00112	0.0013	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—KIT—bone cancer	0.00112	0.00129	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—EGFR—bone cancer	0.00112	0.00129	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—FUS—bone cancer	0.00109	0.00126	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MDM2—bone cancer	0.00109	0.00126	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—MDM2—bone cancer	0.00108	0.00125	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—BRAF—bone cancer	0.00107	0.00124	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—EGFR—bone cancer	0.00107	0.00124	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—EGFR—bone cancer	0.00107	0.00124	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—MDM2—bone cancer	0.00107	0.00123	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—EGFR—bone cancer	0.00106	0.00123	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—GRM4—bone cancer	0.00106	0.00122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—RGS1—bone cancer	0.00106	0.00122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—MMP9—bone cancer	0.00105	0.00122	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—DHFR—bone cancer	0.00105	0.00122	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—EGFR—bone cancer	0.00105	0.00122	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—EGFR—bone cancer	0.00105	0.00121	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PDGFR-beta signaling pathway—JUN—bone cancer	0.00103	0.0012	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—MDM2—bone cancer	0.00103	0.00119	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—GNA11—bone cancer	0.00103	0.00119	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—SPARC—bone cancer	0.00102	0.00118	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—SMO—bone cancer	0.00102	0.00118	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—KIT—bone cancer	0.00101	0.00117	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Apoptosis—TP53—bone cancer	0.001	0.00116	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—NT5C3A—bone cancer	0.000996	0.00115	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—GRM4—bone cancer	0.000986	0.00114	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—RGS1—bone cancer	0.000986	0.00114	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Transmission across Chemical Synapses—BRAF—bone cancer	0.000975	0.00113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—MDM2—bone cancer	0.000972	0.00112	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—EIF2S1—bone cancer	0.000971	0.00112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—MDM2—bone cancer	0.000967	0.00112	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—PLAU—bone cancer	0.000966	0.00112	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—MDM2—bone cancer	0.000962	0.00111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—GRM4—bone cancer	0.000958	0.00111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—RGS1—bone cancer	0.000958	0.00111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—MDM2—bone cancer	0.000957	0.00111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—TP53—bone cancer	0.000956	0.00111	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—BRAF—bone cancer	0.000952	0.0011	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	0.000949	0.0011	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—DHFR—bone cancer	0.000942	0.00109	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—TP53—bone cancer	0.000938	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—EGFR—bone cancer	0.000935	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—GNA11—bone cancer	0.000933	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—GNA11—bone cancer	0.000932	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCD—GPCR downstream signaling—IL3—bone cancer	0.000931	0.00108	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000917	0.00106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—GRM1—bone cancer	0.000915	0.00106	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—MMP9—bone cancer	0.000914	0.00106	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—ENO2—bone cancer	0.000907	0.00105	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—MDM2—bone cancer	0.000901	0.00104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—MDM2—bone cancer	0.000901	0.00104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—MDM2—bone cancer	0.000893	0.00103	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—MDM2—bone cancer	0.000885	0.00102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—MDM2—bone cancer	0.000881	0.00102	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Myometrial Relaxation and Contraction Pathways—JUN—bone cancer	0.000871	0.00101	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—GRM1—bone cancer	0.000854	0.000988	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—EGFR—bone cancer	0.000851	0.000984	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Insulin Signaling—JUN—bone cancer	0.000849	0.000981	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—MDM2—bone cancer	0.000847	0.00098	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—IL3—bone cancer	0.000846	0.000978	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—IL3—bone cancer	0.000845	0.000977	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gene Expression—EZH2—bone cancer	0.000843	0.000975	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—DHFR—bone cancer	0.000841	0.000973	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—JUN—bone cancer	0.00084	0.000971	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—GRM1—bone cancer	0.000831	0.00096	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—PTGS2—bone cancer	0.000817	0.000944	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Transmission across Chemical Synapses—MDM2—bone cancer	0.000817	0.000944	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway and Pluripotency—TP53—bone cancer	0.000803	0.000928	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—MDM2—bone cancer	0.000798	0.000922	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—ATF1—bone cancer	0.000792	0.000915	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CHEK2—bone cancer	0.000787	0.00091	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—ATF1—bone cancer	0.000781	0.000902	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—KIT—bone cancer	0.000779	0.000901	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—KIT—bone cancer	0.000774	0.000894	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—IL3—bone cancer	0.000772	0.000893	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—NR1I2—bone cancer	0.000755	0.000873	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—BRAF—bone cancer	0.000747	0.000863	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—EGFR—bone cancer	0.000738	0.000853	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—JUN—bone cancer	0.000737	0.000851	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—MMP2—bone cancer	0.000736	0.000851	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—BRAF—bone cancer	0.000732	0.000846	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—EGFR—bone cancer	0.00073	0.000844	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—TP53—bone cancer	0.000715	0.000826	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—EGFR—bone cancer	0.000706	0.000817	CbGpPWpGaD
Ingenol Mebutate—PRKCA—M Phase—RB1—bone cancer	0.000702	0.000811	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—BRCA2—bone cancer	0.000667	0.000771	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—EGFR—bone cancer	0.000664	0.000767	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—EGFR—bone cancer	0.000661	0.000764	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—EGFR—bone cancer	0.000661	0.000764	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—EGFR—bone cancer	0.000657	0.00076	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—EGFR—bone cancer	0.000654	0.000756	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Mitotic M-M/G1 phases—RB1—bone cancer	0.000643	0.000744	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Neuronal System—MDM2—bone cancer	0.000626	0.000723	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—EGFR—bone cancer	0.000615	0.000711	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—EGFR—bone cancer	0.000615	0.000711	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—MDM2—bone cancer	0.000614	0.000709	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—EGFR—bone cancer	0.00061	0.000705	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—TGFBR2—bone cancer	0.00061	0.000705	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—MDM2—bone cancer	0.000609	0.000704	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—EGFR—bone cancer	0.000605	0.000699	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—SMO—bone cancer	0.000602	0.000696	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—EGFR—bone cancer	0.000602	0.000696	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—GNA11—bone cancer	0.00059	0.000681	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—SMO—bone cancer	0.000585	0.000677	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—EGFR—bone cancer	0.000579	0.000669	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—RGS1—bone cancer	0.000566	0.000654	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GRM4—bone cancer	0.000566	0.000654	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—EIF2S1—bone cancer	0.000557	0.000644	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—PLAU—bone cancer	0.000555	0.000641	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CDK4—bone cancer	0.000553	0.00064	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—MMP9—bone cancer	0.000553	0.000639	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—GNA11—bone cancer	0.000551	0.000636	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—EGFR—bone cancer	0.000545	0.00063	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—GNA11—bone cancer	0.000535	0.000619	CbGpPWpGaD
Ingenol Mebutate—PRKCA—GPCR downstream signaling—IL3—bone cancer	0.000534	0.000618	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—JUN—bone cancer	0.00053	0.000612	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—bone cancer	0.000527	0.000609	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—ENO2—bone cancer	0.000521	0.000602	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—ATF1—bone cancer	0.000512	0.000592	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IL3—bone cancer	0.000499	0.000577	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CDK4—bone cancer	0.000495	0.000572	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GRM1—bone cancer	0.000491	0.000567	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TP53—bone cancer	0.000486	0.000562	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—IL3—bone cancer	0.000485	0.000561	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gene Expression—EZH2—bone cancer	0.000484	0.00056	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—DHFR—bone cancer	0.000483	0.000559	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—RB1—bone cancer	0.000481	0.000556	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—ATF1—bone cancer	0.000455	0.000526	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—KIT—bone cancer	0.000451	0.000521	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—KIT—bone cancer	0.000444	0.000514	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—IL3—bone cancer	0.000443	0.000513	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ENO2—bone cancer	0.000436	0.000504	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—RB1—bone cancer	0.00043	0.000497	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TGFBR2—bone cancer	0.000427	0.000494	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—EGFR—bone cancer	0.000419	0.000485	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—EGFR—bone cancer	0.000416	0.000481	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—KIT—bone cancer	0.000416	0.000481	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—DHFR—bone cancer	0.000405	0.000468	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—IGF1R—bone cancer	0.000402	0.000464	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—BRAF—bone cancer	0.000391	0.000452	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TP53—bone cancer	0.000388	0.000449	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GNA11—bone cancer	0.000378	0.000437	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—MDM2—bone cancer	0.000367	0.000424	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—MDM2—bone cancer	0.000355	0.00041	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—TGFBR2—bone cancer	0.00035	0.000405	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—MDM2—bone cancer	0.00035	0.000405	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—SMO—bone cancer	0.000346	0.0004	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CYP3A4—bone cancer	0.000343	0.000396	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—MDM2—bone cancer	0.000328	0.000379	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—GNA11—bone cancer	0.000316	0.000366	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—PTGS2—bone cancer	0.000316	0.000365	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—JUN—bone cancer	0.000308	0.000357	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—JUN—bone cancer	0.000304	0.000352	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—ATF1—bone cancer	0.000294	0.00034	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—GSTP1—bone cancer	0.000293	0.000339	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—KIT—bone cancer	0.000291	0.000337	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IL3—bone cancer	0.000287	0.000331	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—BRAF—bone cancer	0.000274	0.000317	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—EGFR—bone cancer	0.000265	0.000307	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—KIT—bone cancer	0.000259	0.000299	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TGFBR2—bone cancer	0.000245	0.000283	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—EGFR—bone cancer	0.000243	0.00028	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—EGFR—bone cancer	0.000239	0.000276	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—KIT—bone cancer	0.000239	0.000276	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—IGF1R—bone cancer	0.000231	0.000267	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MDM2—bone cancer	0.000229	0.000265	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—BRAF—bone cancer	0.000225	0.00026	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—EGFR—bone cancer	0.000224	0.000259	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TP53—bone cancer	0.000223	0.000258	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TP53—bone cancer	0.00021	0.000243	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—MDM2—bone cancer	0.000204	0.000236	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—JUN—bone cancer	0.000199	0.000231	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—MMP9—bone cancer	0.000194	0.000224	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—MDM2—bone cancer	0.000188	0.000218	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—PTGS2—bone cancer	0.000181	0.00021	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—JUN—bone cancer	0.000177	0.000205	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—KIT—bone cancer	0.000167	0.000193	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—BRAF—bone cancer	0.000157	0.000182	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—EGFR—bone cancer	0.000157	0.000181	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—EGFR—bone cancer	0.000152	0.000176	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—PTGS2—bone cancer	0.000152	0.000176	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—EGFR—bone cancer	0.000139	0.000161	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MDM2—bone cancer	0.000132	0.000152	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TP53—bone cancer	0.000132	0.000152	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—EGFR—bone cancer	0.000129	0.000149	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—JUN—bone cancer	0.000115	0.000132	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—MMP9—bone cancer	0.000111	0.000129	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EGFR—bone cancer	9.01e-05	0.000104	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TP53—bone cancer	7.56e-05	8.74e-05	CbGpPWpGaD
